BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
-26.78%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$765M
AUM Growth
+$765M
Cap. Flow
-$45.3M
Cap. Flow %
-5.91%
Top 10 Hldgs %
52.72%
Holding
58
New
1
Increased
22
Reduced
25
Closed
3

Top Buys

1
RCUS icon
Arcus Biosciences
RCUS
$14.6M
2
KURA icon
Kura Oncology
KURA
$10.7M
3
MRUS icon
Merus
MRUS
$8.4M
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
$6.86M
5
VSTM icon
Verastem
VSTM
$5.13M

Top Sells

1
IONS icon
Ionis Pharmaceuticals
IONS
$27.6M
2
ARRY
Array Biopharma Inc
ARRY
$22M
3
XNCR icon
Xencor
XNCR
$8.83M
4
KALV icon
KalVista Pharmaceuticals
KALV
$7.04M
5
PTGX icon
Protagonist Therapeutics
PTGX
$6.59M

Sector Composition

1 Healthcare 83.41%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FSTX
26
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$9.89M 1.29%
237,925
-400
-0.2% -$16.6K
REPL icon
27
Replimune Group
REPL
$460M
$9M 1.18%
899,617
-12,235
-1% -$122K
SNDX icon
28
Syndax Pharmaceuticals
SNDX
$1.39B
$8.85M 1.16%
1,987,669
+754,051
+61% +$3.36M
VBIV
29
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8.35M 1.09%
173,895
+70,562
+68% +$3.39M
MEIP icon
30
MEI Pharma
MEIP
$149M
$7.86M 1.03%
148,935
-5,080
-3% -$268K
ARGX icon
31
argenx
ARGX
$44.2B
$7.77M 1.02%
80,868
+4,060
+5% +$390K
CRVS icon
32
Corvus Pharmaceuticals
CRVS
$419M
$6.94M 0.91%
1,890,507
– –
EIGR
33
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6.86M 0.9%
+22,500
New +$6.86M
CDTX icon
34
Cidara Therapeutics
CDTX
$1.61B
$6.83M 0.89%
145,234
+48,700
+50% +$2.29M
IMDZ
35
DELISTED
Immune Design Corp.
IMDZ
$6.74M 0.88%
5,185,383
+527,030
+11% +$685K
FWP
36
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$6.61M 0.86%
1,211,440
-3,264
-0.3% -$17.8K
SPRO icon
37
Spero Therapeutics
SPRO
$117M
$5.19M 0.68%
843,146
-644,942
-43% -$3.97M
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.08M 0.66%
6,929,690
– –
KALV icon
39
KalVista Pharmaceuticals
KALV
$713M
$4.99M 0.65%
252,693
-356,321
-59% -$7.04M
ALBO
40
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$4.92M 0.64%
200,500
-18,300
-8% -$449K
PHXM
41
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.23M 0.55%
62,500
– –
PRNB
42
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$4.01M 0.52%
146,300
-93,700
-39% -$2.57M
OMED
43
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$3.02M 0.39%
4,042,989
– –
CFRX
44
DELISTED
ContraFect Corporation
CFRX
$2.91M 0.38%
2,374
-1,974
-45% -$2.42M
MACK
45
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.79M 0.36%
917,579
-493,978
-35% -$1.5M
ALPN
46
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.37M 0.31%
643,059
– –
SURF
47
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.92M 0.25%
451,850
+91,632
+25% +$389K
FRTX
48
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.52M 0.2%
4,082
-148
-3% -$55K
GNCA
49
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.47M 0.19%
639,307
-18,818
-3% -$43.2K
EPIX icon
50
ESSA Pharma
EPIX
$11.2M
$1.22M 0.16%
580,368
+3,597
+0.6% +$7.56K
1
2
3